PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Critical Care Medicine, Beijing Ditan Hospital, Capital Medical University, No. 8 Jingshundong Street, Chaoyang District, Beijing, 100015, People\'s Republic of China.\', \'Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, People\'s Republic of China.\', \'Center of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, People\'s Republic of China.\', \'Department of Critical Care Medicine, Beijing Ditan Hospital, Capital Medical University, No. 8 Jingshundong Street, Chaoyang District, Beijing, 100015, People\'s Republic of China. liang@ccmu.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12879-021-06595-6
?:doi
?:hasPublicationType
?:journal
  • BMC infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 34461841
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.576
?:rankingScore_hIndex
  • 80
is ?:relation_isRelatedTo_publication of
?:title
  • Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all